Table 1.
Details of the human brain material obtained from the Stanley Foundation
| Brain No. | Diagnosis | Age/sex | Cause of death | Side of brain | Medications at the time of death | Lifetime fluph. eq (mg) | PMI (h) | pH |
|---|---|---|---|---|---|---|---|---|
| S-49 | N | 52/M | CPD | L | None | – | 28 | 6.5 |
| S-70 | N | 44/F | CPD | R | None | – | 25 | 6.3 |
| S-73 | N | 59/M | CPD | R | None | – | 26 | 6.4 |
| S-85 | N | 52/M | CPD | L | None | – | 8 | 6.5 |
| S-123 | N | 52/M | CPD | R | None | – | 22 | 6.2 |
| S-124 | N | 53/M | CPD | L | None | – | 28 | 6.2 |
| S-126 | N | 44/M | CPD | L | None | – | 10 | 6.4 |
| S-136 | N | 35/F | CPD | R | None | – | 23 | 6.6 |
| S-141 | N | 41/M | CPD | R | None | – | 11 | 6 |
| S-149 | N | 42/M | CPD | R | None | – | 27 | 6.6 |
| S-158 | N | 35/F | CPD | L | None | – | 40 | 5.8 |
| S-162 | N | 68/F | CPD | L | None | – | 13 | 6.3 |
| S-165 | N | 58/M | CPD | L | None | – | 27 | 6 |
| S-174 | N | 29/F | Accident | L | None | – | 42 | 6.2 |
| S-179 | N | 57/F | Accident | R | None | – | 26 | 6 |
| S-13 | S, DO, 295.10 | 30/F | Suicide | R | Thx, Des | 6 000 | 60 | 6.2 |
| S-18 | S, UD, 295.92 | 52/M | CPD | L | None (>20 years) | 9 000 | 61 | 6 |
| S-30 | S, UD, 295.92 | 30/M | CPD | L | Ris, Tdz | 50 000 | 32 | 5.8 |
| S-41 | S, P, 295.30 | 62/F | Accident | L | None (7 months) | 50 000 | 26 | 6.1 |
| S-43 | S, UD, 295.92 | 60/F | CPD | L | None (never treated) | 0 | 40 | 6.2 |
| S-64 | S, UD, 295.92 | 60/M | Accident | R | Tdz, Ami | 80 000 | 31 | 6.2 |
| S-66 | S, UD, 295.92 | 32/M | Other | L | Cloz | 15 000 | 19 | 6.1 |
| S-81 | S, UD, 295.92 | 31/M | Suicide | L | Cloz | 4 000 | 14 | 5.8 |
| S-82 | S, P, 295.30 | 58/F | CPD | R | Hal, Dph | 35 000 | 26 | 5.9 |
| S-93 | S, UD, 295.92 | 25/M | Suicide | L | Ris, Par | 4 000 | 32 | 6.6 |
| S-100 | S, UD, 295.92 | 44/M | CPD | R | Hal, Cbz, Fx, Cz, Bz | 100 000 | 50 | 6.5 |
| S-116 | S, P, 295.30 | 44/M | CPD | L | Cloz, Cpz, Li | 130 000 | 29 | 5.9 |
| S-118 | S, UD, 295.92 | 56/F | Suicide | R | Hal, Li, Dph, CH | 150 000 | 12 | 6.4 |
| S-120 | S, P, 295.30 | 35/M | CPD | R | Cloz, Cpz, Ma, Bz, Dph | 50 000 | 35 | 6.5 |
| S-173 | S, UD, 295.92 | 49/F | CPD | L | Hal, Cloz, Cz | >200 000 | 38 | 6.2 |
| S-33 | B, wP, 296.54 | 25/F | Suicide | R | Thx, Cbz, Li, Trz | 7 500 | 24 | 6.4 |
| S-34 | B, wP, 296.64 | 48/F | CPD | L | Val, Ser, Cpx, Cbz | 32 000 | 22 | 5.8 |
| S-47 | B, wP, 296.64 | 37/F | Suicide | R | Li, Bup, Cz, Lz | 1 200 | 29 | 6.5 |
| S-48 | B, woP, 296.45 | 54/M | Other | R | Li, Cbz | 2 500 | 39 | 5.8 |
| S-60 | B, wP, 296.64 | 30/M | CPD | R | Li, Cloz | 60 000 | 31 | 6.1 |
| S-68 | B, woP, 296.53 | 30/M | Suicide | R | None | 0 | 56 | 5.8 |
| S-72 | B, wP, 296.44 | 57/M | CPD | L | Hal, Dph | 60 000 | 19 | 6.2 |
| S-75 | B, wP, 296.54 | 34/M | Suicide | R | Ris, Val, Vfx | 7 000 | 23 | 6.3 |
| S-83 | B, wP, 296.44 | 48/M | Suicide | R | None (>20 years) | <200 | 13 | 6.1 |
| S-88 | B, wP, 296.54 | 31/M | Suicide | R | Hal, Trz, Trx | 30 000 | 28 | 6.3 |
| S-89 | B, II/H, 296.89 | 30/M | Suicide | L | Val, Bup | 0 | 45 | 6.3 |
| S-91 | B, wP, 296.44 | 50/F | Other | L | several months | 12 000 | 18 | 6.1 |
| S-103 | B, wP, 296.54 | 61/F | Suicide | L | Fx, Val | 40 000 | 60 | 6.5 |
| S-128 | B, wP, 296.44 | 50/M | Suicide | L | Val, Cloz, Fz, Bz | 60 000 | 19 | 6.2 |
| S-147 | B, woP, 296.53 | 50/F | CPD | L | Val, Cmi | 0 | 62 | 6.3 |
| S-16 | D, 296.23 | 32/F | Suicide | L | Imi, Ami, Ntp, Cz | 0 | 47 | 6 |
| S-38 | D, 296.33 | 53/F | Other | R | Li, Trz | 0 | 40 | 6.3 |
| S-46 | D, 296.33 | 44/F | Suicide | L | Fx, Imi, Lz | 0 | 32 | 6.2 |
| S-59 | D, 296.33 | 65/M | CPD | R | Pht (single seizure) | 0 | 19 | 6.2 |
| S-92 | D, NOS:311, woP | 52/M | CPD | R | None (6 years) | 0 | 12 | 6.5 |
| S-99 | D, 296.33 | 46/M | Suicide | R | Dph, Cz | 0 | 26 | 6.1 |
| S-101 | D, 296.22 | 42/F | CPD | R | Fx, Li | 0 | 25 | 6.3 |
| S-104 | D, 296.23 | 51/M | Suicide | R | Nef, Hxz | 0 | 26 | 6.3 |
| S-135 | D, 296.33 | 39/M | Suicide | L | None | 0 | 23 | 6 |
| S-138 | D, 296.31 | 42/M | Suicide | L | None (>2 weeks) | 0 | 7 | – |
| S-156 | D, 296.32 | 56/M | CPD | L | Ser | 0 | 23 | 6.5 |
| S-163 | D, 296.33 | 56/F | CPD | L | Vfx, Bus, Az | 0 | 28 | 5.8 |
| S-168 | D, 296.33 | 30/F | Suicide | L | Ntp, Az, Cmi | 0 | 33 | 6 |
| S-171 | D, 296.33 | 43/M | CPD | L | Tri | 0 | 43 | 5.9 |
| S-172 | D, 296.33 | 47/M | CPD | L | Fx, Nef | 0 | 28 | 6.4 |
Ami, amitriptyline; Az, alprazolan; B, II/H, bipolar II disorder, hypomaniac; B, woP, bipolar disorder without psychotic features; B, wP, bipolar disorder with psychotic features; Bup, bupropion; Bus, buspirone; Bz, benzotropine; Cbz, carbamazepine; CH, chloral hydrate; Cloz, clozapine; Cmi, clomipramine; CPD, cardiopulmonary diseases; Cpx, chlorprothixene; Cpz, chlorpromazine; Cz, clonazepam; D, major depression; Des, desipramine; Dph, diphenhydramine; F, female; Fx, fluoxetine; Fz, flurazepam; Hal, haloperidol; Hxz, hydroxyzine; Imi, imipramine; L, left hemisphere; Li, lithium; Lifetime fluph. eq, estimated lifetime antipsychotics in fluphenazine equivalents; Lz, lorazepam; M, male; Ma, maprotiline; N, normal control; Nef, nefazadone; Ntp, nortriptyline; Par, paroxetine; Pht, phenytoin; PMI, post-mortem interval; R, right hemisphere; Ris, risperidone; S, DO, schizophrenia, disorganized; S, P, schizophrenia, paranoid; S, UD, schizophrenia, undifferentiated; Ser, sertraline; Tdz, thioridazine; Thx, thiothixene; Tri, trimipramine; Trz, trazadone; Trx, trihexphenidyl; Val, valproate; Vfx, venlafaxine.